We will invite experts who are active at the forefront of regenerative medicine, biopharmaceuticals, and immune cell research to share the latest research information and future possibilities!
This seminar is fully booked. Thank you for the many attendees. You will hear a wide range of lectures from basic research in academia to industrial applications in pharmaceuticals and venture companies. A networking event will also be held after the seminar. We look forward to your participation. [Nova Advanced Cell Science Seminar - The Future Opened by Cultured Cells] ■ Date: August 1, 2019 (Thursday) 1:00 PM - 6:00 PM (Networking event 6:00 PM -) ■ Venue: Shinagawa Prince Hotel Main Tower Diamond 30 ■ Participation Fee: Free (Networking event participation: Free) ■ Capacity: 200 people ■ Organized by: Nova Biomedical Corporation Application Deadline: July 22 (Monday) *Applications are closed due to full capacity.
Inquire About This Product
basic information
■Introduction of Speakers (in Program Order) 1. The Importance of Media Measurement in Cultivation Contributing to Regenerative Medicine Dr. Masahiro Kinooka (Professor, Graduate School of Engineering, Osaka University) 2. Realizing Scaled-Up Production of Platelets Derived from iPS Cells ~From Early Practical Research to Clinical Development~ Dr. Tomohiro Shigemori (Research and Development Manager, Megakaryon Corporation) 3. Diversity of CART Cells Dr. Hiroshi Tamaki (Professor, Department of Pathophysiology, Graduate School of Medicine, Mie University) 4. The Past and Future of Antibody Drug Development at Chugai Pharmaceutical! (Tentative Title) Dr. Shin Hirajima (CMC Development Department, Pharmaceutical Headquarters, Chugai Pharmaceutical Co., Ltd.) 5. From Antibody Drugs to Gene Therapy - Considering Production Technology Dr. Kenji Omasa (Professor, Department of Advanced Molecular Engineering, Graduate School of Engineering, Osaka University)
Price range
Delivery Time
Applications/Examples of results
catalog（5）
Download All Catalogs
![[Product Specifications] Automatic Analysis Device for Cell Culture Environment 'BioProfile FLEX2'](https://image.mono.ipros.com/public/catalog/image/01/2d4/423790/IPROS10785152400559635376.jpeg?w=120&h=170)
![[Verification Material] The Importance of Analyzing Culture Medium Components in iPS Cell Cultivation](https://image.mono.ipros.com/public/catalog/image/01/38c/440458/IPROS56142213031488853103.jpeg?w=120&h=170)
![(Full Capacity Registration Closed) Free Seminar Held! August 1, 2019 (Thursday) [The Future Opened by Cultured Cells]](https://image.mono.ipros.com/public/catalog/image/01/187/469166/IPROS56755930089167033618.jpeg?w=120&h=170)
![Online seminar held on September 29, 2020 (Tuesday)! [The Future Opened by Cultured Cells]](https://image.mono.ipros.com/public/catalog/image/01/f6e/532321/IPROS46323668016030085800.jpeg?w=120&h=170)
Company information
Nova Biomedical Corporation is a bio-medical company headquartered in Boston, USA. Since the development of the ionized calcium sensor in 1978, we have successfully commercialized innovative biosensors and have been providing innovative products that reflect the needs of medical settings and clinical research fields to this day. Our "automated analysis system for cell culture environments" supports research in fields such as "regenerative medicine" and "gene drug discovery." In the fortunate environment known as "Boston Bio Valley," we leverage cutting-edge science and technology to deliver better products to doctors, nurses, technicians, and researchers, continuously challenging ourselves to innovate. We have provided innovative products that reflect the needs of medical settings up to the present day. We will continue to support healthcare professionals and researchers to provide solutions as quickly as possible to patients suffering from difficult diseases. Our company has over 1,000 employees, with sales and service subsidiaries in eight countries and distributors in more than 90 countries. Nova Biomedical's products are being adopted worldwide.